PAM
TNYA icon

Panagora Asset Management’s Tenaya Therapeutics TNYA Stock Holding History

Panagora Asset Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,223
Closed -$13.2K – 1215
2025
Q1 		$13.2K Sell
23,223
-106,426
-82% -$105K ﹤0.01% 1097
2024
Q4 		$185K Sell
129,649
-875
-0.7% -$1.96K ﹤0.01% 1083
2024
Q3 		$252K Buy
130,524
+77,780
+147% +$220K ﹤0.01% 1089
2024
Q2 		$164K Buy
+52,744
New +$218K ﹤0.01% 1147

Other funds holding TNYA

CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Panagora Asset Management's TNYA Position: Q2 2025 in Review

Panagora Asset Management sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 23,223 shares — an estimated $13.2K sold.

Panagora Asset Management first reported a position in TNYA in Q2 2024 and held it in 4 quarters. The position peaked at $252K in Q3 2024. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

  • Panagora Asset Management reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Panagora Asset Management sold 23,223 Tenaya Therapeutics shares in Q2 2025, an estimated $13.2K.
  • Panagora Asset Management first reported a position in Tenaya Therapeutics in Q2 2024 and held it in 4 quarters.
  • Panagora Asset Management's Tenaya Therapeutics position peaked at $252K in Q3 2024.
  • 89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on Panagora Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.